<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Hansa Biopharma Reports Second Quarter and Interim ..]]></title><description><![CDATA[<p dir="auto">Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-reports-second-quarter-and-interim-january-june-2025-financial-results,c4208006" title="Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results">
<img src="https://mb.cision.com/Public/1219/logo/961eb95ced00be7f_org.png" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>







<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-reports-second-quarter-and-interim-january-june-2025-financial-results,c4208006">
Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results
</a>
</h5>
<p class="card-text line-clamp-3">· Hansa secures directed cash share issue of approximately 232 MSEK/US $24.3M and restructures</p>
</div>
<a href="https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-reports-second-quarter-and-interim-january-june-2025-financial-results,c4208006" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://news.cision.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0">News Powered by Cision <span class="text-secondary">(news.cision.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/447437/hansa-biopharma-reports-second-quarter-and-interim</link><generator>RSS for Node</generator><lastBuildDate>Fri, 12 Jun 2026 20:41:08 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/447437.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 17 Jul 2025 03:04:07 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Hansa Biopharma Reports Second Quarter and Interim .. on Thu, 17 Jul 2025 03:32:52 GMT]]></title><description><![CDATA[<p dir="auto">Half Year Report January - July 2025</p>
<p dir="auto"><a href="https://www.hansabiopharma.com/files/Main/1219/4208006/20250717_hnsa_q22025_quarterlyreport_eng.pdf" rel="nofollow ugc">https://www.hansabiopharma.com/files/Main/1219/4208006/20250717_hnsa_q22025_quarterlyreport_eng.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9493741</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9493741</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 17 Jul 2025 03:32:52 GMT</pubDate></item></channel></rss>